Ketamine Clinical Trials
Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room.
To see complete record on clinicaltrials.gov, please visit this link
Id: NCT01517828
Organisation Name: University Hospital, Montpellier
Overal Status: Unknown status
Start Date: January 2012
Last Update: December 3, 2014
Lead Sponsor: University Hospital, Montpellier
Brief Summary: Anesthesia is rarely used to intubate newborns in delivery room because of the very difficulty of accessing veins. The investigators hypothesized that intranasal administration of sedative would be an effective alternative. -Midazolam and Ketamine are two drugs used during neonates' intubation. They are also used intranasally in the absence of venous access-In a pilot study the investigators have demonstrated that sedation with Midazolam was effective in 67% of the patients. Efficiency was defined by a specific pain score: FANS < 4 (Faceless Acute Neonatal Pain Scale) and by an impedancemetric Pain monitor < 0.2 spike/s.
The investigators hypothesized that intranasal ketamine would increase procedure effectiveness from 67 to 90%.
Main objective: To compare newborns sedation quality as they are sedated either by intranasal Midazolam or by intranasal Ketamine during intubation in delivery room.
Secondary Objectives: To compare intubation quality, hemodynamic and respiratory tolerance, and neurological outcomeat 2 years within the two groups.
Conditions:
- Respiratory Distress Syndrome
- Prematurity of Fetus
Total execution time in seconds: 0.27635884284973